Phase IIa trial of FP 01-Immune Targeting Systems (Flunisyn) in elderly patients

Trial Profile

Phase IIa trial of FP 01-Immune Targeting Systems (Flunisyn) in elderly patients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Apr 2013

At a glance

  • Drugs FP 01-Immune Targeting Systems (Primary) ; Influenza virus vaccine
  • Indications Influenza A virus infections; Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2013 Positive results were presented at World Vaccine Congress, according to an Immune Targeting Systems media release.
    • 18 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top